Evidence map›Paper›PMID 31168892›Full record

ArticleHuman brain mapping2019

Modeling longitudinal imaging biomarkers with parametric Bayesian multi-task learning.

Leon M Aksman, Marzia A Scelsi, Andre F Marquand, Daniel C Alexander, Sebastien Ourselin, Andre Altmann, for ADNI

Abstract read
In one paragraph

Article in Human brain mapping, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leon M AksmanCentre for Medical Image Computing, University College London, London, UK.ORCID 0000-0003-2342-0780
Marzia A ScelsiCentre for Medical Image Computing, University College London, London, UK.
Andre F MarquandDonders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Daniel C AlexanderCentre for Medical Image Computing, University College London, London, UK.
Sebastien OurselinCentre for Medical Image Computing, University College London, London, UK.
Andre AltmannCentre for Medical Image Computing, University College London, London, UK.
for ADNI

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI Duygu Tosun-Turgut · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
GLUTATHIONE IN BRAIN TUMOR RESISTANCE TO NITROSOUREASR29CA046410 · NCI · UNIVERSITY OF WASHINGTON · PI ALI-OSMAN, FRANCIS · 1988 to 1992
–
Engineering and Physical Sciences Research Council EP/H046410/1Engineering and Physical Sciences Research Council EP/J020990/1Engineering and Physical Sciences Research Council EP/K005278Engineering and Physical Sciences Research Council EP/L016478/1Engineering and Physical Sciences Research Council J020990Engineering and Physical Sciences Research Council M006093Engineering and Physical Sciences Research Council M020533FP7 Information and Communication Technologies FP7-ICT-2011-9-601055Horizon 2020 Framework Programme 666992Medical Research Council MR/J01107X/1Medical Research Council MR/L016311/1National Institute for Health Research BW.mn.BRC10269Nederlandse Organisatie voor Wetenschappelijk Onderzoek 91716415NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG024904
6 · The paper itself

Abstract

Longitudinal imaging biomarkers are invaluable for understanding the course of neurodegeneration, promising the ability to track disease progression and to detect disease earlier than cross-sectional biomarkers. To properly realize their potential, biomarker trajectory models must be robust to both under-sampling and measurement errors and should be able to integrate multi-modal information to improve trajectory inference and prediction. Here we present a parametric Bayesian multi-task learning based approach to modeling univariate trajectories across subjects that addresses these criteria. Our approach learns multiple subjects' trajectories within a single model that allows for different types of information sharing, that is, coupling, across subjects. It optimizes a combination of uncoupled, fully coupled and kernel coupled models. Kernel-based coupling allows linking subjects' trajectories based on one or more biomarker measures. We demonstrate this using Alzheimer's Disease Neuroimaging Initiative (ADNI) data, where we model longitudinal trajectories of MRI-derived cortical volumes in neurodegeneration, with coupling based on APOE genotype, cerebrospinal fluid (CSF) and amyloid PET-based biomarkers. In addition to detecting established disease effects, we detect disease related changes within the insula that have not received much attention within the literature. Due to its sensitivity in detecting disease effects, its competitive predictive performance and its ability to learn the optimal parameter covariance from data rather than choosing a specific set of random and fixed effects a priori, we propose that our model can be used in place of or in addition to linear mixed effects models when modeling biomarker trajectories. A software implementation of the method is publicly available.

Indexed as

Machine LearningModels, TheoreticalAlzheimer DiseaseBayes TheoremBiomarkersCerebral CortexComputer SimulationDatasets as TopicHumansLongitudinal StudiesMagnetic Resonance ImagingNeuroimagingBiomarkersAlzheimer's diseaseBayesian analysisbiomarkerslongitudinal analysismachine learningmultimodal analysisstructural MRI

Identifiers

PMID31168892
PMCPMC6679792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.